NCT00562172View on ClinicalTrials.gov

Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)

PHASE4CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Insulin glargine

Once daily in the morning

DRUG

Glimepiride

Once daily in the morning

DRUG

Metformin

At least 1000 mg/day

Trial Locations (1)

Unknown

Sanofi-aventis, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY